BNTX News and Press, BioNTech SE From 03/27/23

2023-03-27 15:34:05 ET BioNTech SE (BNTX) Q4 2022 Results Conference Call March 27, 2023 08:00 AM ET Company Participants Michael Horowicz - IR and Strategy Ugur Sahin - CEO and Co-Founder Özlem Türeci - Chief Medical Officer and Co-Founder Jens Hol...

2023-03-27 15:06:59 ET Shares of vaccine maker BioNTech (NASDAQ: BNTX) were down 2.8% early Monday afternoon after falling as much as 6.4% earlier in the day. The decline came after the biotech company reported fourth-quarter and full-year earnings before the markets opened on M...

2023-03-27 09:13:05 ET Stocks looked poised for a further upswing in Monday's premarket trading, adding to gains posted at the end of last week. Continued easing of worries about the banking sector boosted sentiment. Here are some stocks to watch on Monday: First Citizens Bank ( NAS...

2023-03-27 08:12:51 ET The following slide deck was published by BioNTech SE in conjunction with their 2022 Q4 earnings call. For further details see: BioNTech SE 2022 Q4 - Results - Earnings Call Presentation

2023-03-27 07:29:26 ET BioNTech ( NASDAQ: BNTX ), the German partner of Pfizer ( PFE ) for the Comirnaty COVID vaccine, lost ~3% pre-market Monday after announcing its Q4 2022 financials and projecting that its share of vaccine revenue could reach ~€5B this year...

2023-03-27 06:54:11 ET BioNTech press release ( NASDAQ: BNTX ): Q4 GAAP EPS of €9.26 beats by €1.51 . Revenue of €4.28B (-22.6% Y/Y) beats by €420M . Expanded and advanced oncology pipeline to 20 programs in 24 ongoing clinical trial...

Expanded and advanced oncology pipeline to 20 programs in 24 ongoing clinical trials including five ongoing randomized Phase 2 clinical trials; multiple trials with registrational potential expected to be initiated in 2023 and 2024 Announced licensing agreement with OncoC4 to compleme...

2023-03-25 17:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-24 13:48:26 ET The pace of earnings releases has slowed to a thin trickle as March heads towards its close. Still, a number of closely watched results are due out next week. These will cover notable players in the pharmaceutical, technology and retail industries, providing key i...

2023-03-24 11:07:24 ET BioNTech ( NASDAQ: BNTX ) is scheduled to announce Q4 earnings results on Monday, March 27th, before market open. The consensus EPS Estimate is $8.40 and the consensus Revenue Estimate is $4.19B Over the last 3 months, EPS estimates have seen 3 ...